The US Food and Drug Administration reveals it’s received 118 adverse event complaints from AG1 users – this year alone. In particular, there are 30-plus reports of liver harm in 2023 and 2024.
The billion dollar company dismisses the liver harm complaints as “extremely rare”, saying it can be caused by a range of things such as alcoholic liver injury, viral hepatitis and autoimmune disease. The FDA hasn’t investigated the complaints to confirm whether they are indeed caused by AG1 – but some consumers and scientists are calling for an official investigation into this glamour product championed by superstar influencers.
Each episode is available first to subscribers to DELVE+. To listen early and ad-free to this show, to our bonus episodes, and to award-winning podcast The Boy in the Water and Melanie Reid’s latest investigation, Fractured, sign up to DELVE+.
","author_name":"newsroom.co.nz"}